Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
Table 2
Distribution of patients, response, and relapses after chemoradiotherapy of 60 patients according to site.
Total
Hypopharynx
Larynx
Notes
(%)
(%)
(%)
Response
60 (100)
34 (56.5)
26 (43.5)
Complete response
53 (88.3)
30 (88.2)
23 (88.5)
Residual disease
7 (11.7)
4 (11.8)
3 (11.5)
3/7 patients underwent salvage surgery (all laryngectomies)
Relapse
Locoregional relapse
15 (28.3)
8 (26.7)
7 (30.4)
14/15 patients underwent salvage surgery (7 laryngectomies)
